Table 4.
Associations between sociodemographic and clinical characteristics and sexual function among men with severe obesity prior to bariatric surgery.
| Lower frequency of sexual desire |
Lower frequency of sexual activity |
Higher degree physical health limits sexual activity |
Lower satisfaction with sex life |
Lower IWQOL-Lite sexual life score |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OR | (95%CI) | P | OR | (95%CI) | P | OR | (95%CI) | P | OR | (95%CI) | P | β | (95%CI) | P | |
| Age, per 10 year | 2.07 | (1.57–2.75) | <.0001 | 2.08 | (1.62–2.66) | <.0001 | 1.43 | (1.10–1.85) | 0.01 | 1.85 | (1.44–2.37) | <.0001 | 8.32 | (5.66–10.97) | <.0001 |
| White race (Ref.=black/other race) | 0.94 | (0.30–2.90) | 0.91 | 1.83 | (0.68–4.98) | 0.23 | 0.80 | (0.30–2.16) | 0.66 | 0.56 | (0.21–1.50) | 0.25 | −0.70 | (−11.53–10.14) | 0.90 |
| Hispanic ethnicity (Ref.=No) | 0.60 | (0.11–3.25) | 0.55 | 0.98 | (0.24–3.93) | 0.97 | 1.46 | (0.34–6.28) | 0.61 | 1.17 | (0.29–4.74) | 0.82 | −1.94 | (−17.39–13.50) | 0.80 |
| Education (Ref.= College degree) | 0.02 | ||||||||||||||
| Some college | 1.70 | (0.96–3.00) | |||||||||||||
| High school degree or less | 2.48 | (1.28–4.79) | |||||||||||||
| Not married/living as married (Ref.=Yes) | 1.73 | (0.87–3.40) | 0.12 | 1.87 | (1.02–3.41) | 0.04 | 0.66 | (0.36–1.22) | 0.19 | 1.93 | (1.05–3.55) | 0.03 | 6.75 | (0.02–13.48) | 0.049 |
| BMI, per 5 kg/m2 | 1.09 | (0.91–1.31) | 0.37 | 1.02 | (0.86–1.20) | 0.86 | 1.25 | (1.06–1.47) | 0.01 | 1.05 | (0.89–1.24) | 0.54 | 2.19 | (0.37–4.00) | 0.02 |
| Beck Depression Inventory score, per 5 points | 1.22 | (0.98–1.52) | 0.07 | 1.00 | (0.82–1.23) | 0.96 | 1.74 | (1.42–2.13) | <.0001 | 1.93 | (1.56–2.40) | <.0001 | 7.46 | (5.27–9.66) | <.0001 |
| Diabetes (Ref.=No diabetes) | 0.01 | ||||||||||||||
| Without insulin | 2.98 | (1.48–5.98) | |||||||||||||
| With insulin | 1.41 | (0.75–2.64) | |||||||||||||
| Anti-depressant medications that may decrease sexual function b (Ref.=No) | 1.97 | (1.05–3.72) | 0.04 | 2.40 | (1.34–4.31) | 0.003 | 1.74 | (0.96–3.15) | 0.07 | 1.11 | (0.61–2.00) | 0.73 | 7.12 | (0.65–13.59) | 0.03 |
| Anti-hypertensive medications that may decrease sexual function (Ref.=No) | 0.81 | (0.44–1.48) | 0.49 | 0.90 | (0.52–1.54) | 0.69 | 1.22 | (0.70–2.12) | 0.49 | 1.11 | (0.65–1.92) | 0.70 | 3.11 | (−2.90–9.11) | 0.31 |
| Medications that may increase sexual function d (Ref.=No) | 1.28 | (0.44–3.70) | 0.65 | 0.68 | (0.26–1.82) | 0.45 | 0.79 | (0.30–2.08) | 0.63 | 0.70 | (0.26–1.93) | 0.49 | 0.99 | (−9.95–11.92) | 0.86 |
a
Adjusted odds ratios (OR)a from mixed effects ordinal logistic regression models or Beta coefficients from a generalized linear mixed model and 95% CI are reported. OR represent the odds of being in the next lower category
b
Antidepressant medications other than bupropion, trazodone, mirtazapine or nefazodone.
c
Beta-adrenergic blockers and diuretics were categorized as antihypertensive medications that may impair sexual function.
d
Phosphodiesterase type 5 inhibitors, bupropion, and androgens